Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Somatostatin receptor ligands synthesized by Novo Nordisk

Feb. 2, 1998

Schering-Plough to copromote Novo Nordisk's Prandin

Jan. 30, 1998

Oxytocin antagonist licensed by Tokyo Tanabe enters clinic

Jan. 30, 1998

Roche patents vitamin D analogues for osteoporosis

Jan. 30, 1998

Comparative trial of intracavernous alprostadil and MUSE for ED

Jan. 29, 1998

BioMarin's lead enzyme replacement therapy enters clinical trials

Jan. 28, 1998

Common variant of CETP gene correlated with atherosclerosis progression, response to pravastatin

Jan. 27, 1998

Wyeth-Ayerst licenses PEPCK-modulating compounds

Jan. 27, 1998

Squalene synthase inhibitors patented by Pfizer

Jan. 26, 1998

Alkermes, Johnson & Johnson to codevelop novel formulation of erythropoietin

Jan. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...